Proliferative Vitreoretinopathy Market will reach nearly US$ 660 Mn by 2027-end
With the rise in emphasis on prevention and treatment of proliferative vitreoretinopathy (PVR), a serious ailment that leads to blindness despite repeated treatment, the requirement […]